» Articles » PMID: 20932690

Craniospinal Irradiation Techniques: a Dosimetric Comparison of Proton Beams with Standard and Advanced Photon Radiotherapy

Overview
Specialties Oncology
Radiology
Date 2010 Oct 12
PMID 20932690
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the dosimetric benefits of advanced radiotherapy techniques for craniospinal irradiation in cancer in children.

Methods And Materials: Craniospinal irradiation (CSI) using three-dimensional conformal radiotherapy (3D-CRT), tomotherapy (TOMO), and proton beam treatment (PBT) in the scattering mode was planned for each of 10 patients at our institution. Dosimetric benefits and organ-specific radiation-induced cancer risks were based on comparisons of dose-volume histograms (DVHs) and on the application of organ equivalent doses (OEDs), respectively.

Results: When we analyzed the organ-at-risk volumes that received 30%, 60%, and 90% of the prescribed dose (PD), we found that PBT was superior to TOMO and 3D-CRT. On average, the doses delivered by PBT to the esophagus, stomach, liver, lung, pancreas, and kidney were 19.4 Gy, 0.6 Gy, 0.3 Gy, 2.5 Gy, 0.2 Gy, and 2.2 Gy for the PD of 36 Gy, respectively, which were significantly lower than the doses delivered by TOMO (22.9 Gy, 4.5 Gy, 6.1 Gy, 4.0 Gy, 13.3 Gy, and 4.9 Gy, respectively) and 3D-CRT (34.6 Gy, 3.6 Gy, 8.0 Gy, 4.6 Gy, 22.9 Gy, and 4.3 Gy, respectively). Although the average doses delivered by PBT to the chest and abdomen were significantly lower than those of 3D-CRT or TOMO, these differences were reduced in the head-and-neck region. OED calculations showed that the risk of secondary cancers in organs such as the stomach, lungs, thyroid, and pancreas was much higher when 3D-CRT or TOMO was used than when PBT was used.

Conclusions: Compared with photon techniques, PBT showed improvements in most dosimetric parameters for CSI patients, with lower OEDs to organs at risk.

Citing Articles

Dynamics and predictors of hematologic toxicity during cranio-spinal irradiation.

Turcas A, Homorozeanu B, Gheara C, Balan C, Cosnarovici R, Diaconu O Rep Pract Oncol Radiother. 2024; 29(3):362-372.

PMID: 39144265 PMC: 11321791. DOI: 10.5603/rpor.101094.


Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population.

Savagner J, Ducassou A, Cabarrou B, Hangard G, Gambart M, Bertozzi A Clin Transl Radiat Oncol. 2024; 46:100777.

PMID: 38628594 PMC: 11019098. DOI: 10.1016/j.ctro.2024.100777.


Comparison of passive-scattered and intensity-modulated proton beam therapy of craniospinal irradiation with proton beams for pediatric and young adult patients with brain tumors.

Fukumitsu N, Kubota H, Demizu Y, Suzuki T, Hasegawa D, Kosaka Y Jpn J Radiol. 2023; 42(2):182-189.

PMID: 37874526 PMC: 10811119. DOI: 10.1007/s11604-023-01499-8.


Comparison of Craniospinal Irradiation Using Proton Beams According to Irradiation Method and Initial Experience Treating Pediatric Patients.

Fukumitsu N, Kubota H, Mima M, Demizu Y, Suzuki T, Hasegawa D Adv Radiat Oncol. 2023; 8(5):101251.

PMID: 37408669 PMC: 10318217. DOI: 10.1016/j.adro.2023.101251.


Clinical Characterization of a Table Mounted Range Shifter Board for Synchrotron-Based Intensity Modulated Proton Therapy for Pediatric Craniospinal Irradiation.

Hrinivich W, Li H, Tran A, Acharya S, Ladra M, Sheikh K Cancers (Basel). 2023; 15(11).

PMID: 37296845 PMC: 10251994. DOI: 10.3390/cancers15112882.